Health Canada has approved a second generic version of Ozempic, made by Toronto-based Apotex, just days after authorizing the first generic from India’s Dr. Reddy’s Laboratories. The move is expected ...

Hershey’s CEO says an 8% sales jump in Ice Breakers mints and gum is tied to GLP‑1 weight‑loss drug use, which can cause bad breath. The drugs, including Ozempic, Wegovy and Mounjaro, slow digestion ...

Health Canada has approved a second generic version of semaglutide, the drug in Ozempic, just days after the first, making Canada the first G7 country to do so. The move is expected to lower costs ...

The growing use of GLP-1 weight loss drugs is influencing both consumer habits and health research. Food companies like Hershey report rising sales of mints, gum, and protein bars linked to users ...

Hershey beat first-quarter earnings estimates, driven partly by an 8% jump in Ice Breakers gum and mint sales linked to rising GLP-1 drug use. CEO Kirk Tanner highlighted 'functional snacking' as a ...

People using high-profile weight-loss drugs aren't just changing how they eat—they're reshaping the candy aisle. Hershey says ...

Hershey has credited an 8% rise in Ice Breakers mints and gum sales to the side effects of popular GLP-1 weight-loss drugs like Ozempic. CEO Kirk Tanner said the surge stems from 'Ozempic breath', a ...

Hershey reported an 8% sales increase for its Ice Breakers gum and mints, citing higher demand connected to the growing use of GLP-1 weight-loss drugs like Ozempic. Some users have reported 'Ozempic ...

Hershey says it's benefiting from the growing use of GLP-1 weight-loss drugs even as people cut down on snacks. Here's why.

Hershey says its gum and mint products have gotten a boost from the popularity of GLP-1 drugs. "We've also seen strong demand ...